Meteora Capital’s Day One Biopharmaceuticals DAWN Stock Holding History

Meteora Capital’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-8,900	Closed	-$191K	–	446
2026 Q1	$191K	Buy	+8,900	New	+$125K	0.01%	198

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Meteora Capital's DAWN Position: Q2 2026 in Review

Meteora Capital sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 8,900 shares — an estimated $191K sold.

Meteora Capital first reported a position in DAWN in Q1 2026 and held it in 1 quarter. The position peaked at $191K in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

Meteora Capital reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
Meteora Capital sold 8,900 Day One Biopharmaceuticals shares in Q2 2026, an estimated $191K.
Meteora Capital first reported a position in Day One Biopharmaceuticals in Q1 2026 and held it in 1 quarter.
Meteora Capital's Day One Biopharmaceuticals position peaked at $191K in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Meteora Capital's 13F filing for Q2 2026, filed 14 Aug 2026.